CorMedix Inc. (CRMD) stock
CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.67−0.15 (-3.11%)
Close on Nov 17, 2026Market cap $364.00MP/E –Yield –
CorMedix pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
CorMedix's pe ratio was 2.2× on Nov 11, 2026, against 4.7× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.2× | −3.4 |
| 2025 | Dec 31, 2025 | 5.6× | – |
See a number that looks wrong?